Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical ...

Data from Bayer’s cardiovascular portfolio in heart failure and cardiac amyloidosis will be presented, including ...

SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid Eye ...

Belarusian cardiology has made significant progress, but doctors and scientists need to continue working closely together to ...

AdvaMed recommends several steps that could strengthen the RAPID pathway for breakthrough medical technologies.

A $25 million gift from the Smilow Foundation, led by William Smilow, will establish the Smilow Center for Precision ...

Strong financials, accelerated growth trends, and a guidance update reflect on a favorable outlook for Medtronic plc ...

Two-year clinical follow-up presented at EACTS 2026, highlighting the potential of Vascudyne’s bioengineered platform technology EACTS Photos presents at EACTS 2026 in Barcelona. Abby Krouse ...

New model enables researchers to explore how Hutchinson-Gilford Progeria Syndrome affects three layers of cells in blood ...

Congress 2026 opened in Abu Dhabi on Thursday, bringing together approximately 1,200 physicians and healthcare professionals, alongside leading medical experts from 30 countries.Under the patronage ...

Posts Not To Miss From GCOS 2026 / Aaron Sverdlov, Alexander Lyon, amyloidosis, Artificial Intelligence in Cardio-Oncology, ...

TLANDO is approved by Health Canada as a testosterone replacement therapy in adult males indicated for conditions associated with a deficiency or absence of endogenous testosterone (male hypogonadism) ...